Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
QuintilesIMS
Johnson and Johnson
AstraZeneca
Daiichi Sankyo
Cantor Fitzgerald
US Army
Harvard Business School
Chubb
Citi

Generated: August 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 080744

« Back to Dashboard
NDA 080744 describes TRIPELENNAMINE HYDROCHLORIDE, which is a drug marketed by Nylos, Watson Labs, Parke Davis, Anabolic, Barr, Lannett, Impax Labs, and Heather, and is included in eleven NDAs. Additional details are available on the TRIPELENNAMINE HYDROCHLORIDE profile page.

The generic ingredient in TRIPELENNAMINE HYDROCHLORIDE is tripelennamine hydrochloride. There is one drug master file entry for this compound. Additional details are available on the tripelennamine hydrochloride profile page.

Summary for NDA: 080744

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
UBS
Argus Health
Novartis
Fuji
Fish and Richardson
Chubb
Colorcon
Dow
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot